Home » Topics » Regulatory » Patents

Patents
RSS

E. Merck claims oxazolidinone adhesion receptor antagonists

May 24, 1996

Na+/K+-ATPase inhibitors disclosed by Sigma-Tau

May 24, 1996

More angiotensin II antagonists from Japanese companies

May 24, 1996

ADIR claims compounds for venous insufficiency

May 24, 1996

ADIR claims imidazoline I1 receptor ligands for hypertension

May 24, 1996

Zeneca reports antiasthmatic NK1/NK2 antagonists

May 24, 1996

PLA2 inhibitors claimed by AHP for asthma, inflammatory conditions

May 24, 1996

Sankyo's calpain inhibitor for neurological disorders, restenosis

May 24, 1996

E. Merck describes NMDA ligands for neurodegeneration

May 24, 1996

Lilly's new series of muscarinic cholinergic receptor agonists

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026